Main Content

AstraZeneca vaccine may take longer to get FDA approval


AstraZeneca’s CEO is telling Bloomberg News that the company might conduct another international study of its coronavirus vaccine candidate that might take longer to get FDA approval. NBC’s Gabe Gutierrez reports for TODAY.

News and Information Daytime Highlight
Appearing:Savannah Guthrie
Tags: news, Editor's picks, big news, today


We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences. By using the site, you consent to these cookies. For more information on cookies including how to manage your consent visit our cookie policy.